IRIN Examines MDR-TB In Myanmar

IRIN examines the issue of multidrug-resistant tuberculosis (MDR-TB) in Myanmar, writing, “Inadequate detection and treatment are major obstacles and can result in cases of drug-resistant TB (DR-TB) such as MDR-TB, say health experts.” According to Peter Paul de Groote, Myanmar’s head of mission for Médecins Sans Frontières (MSF), “Drug-resistant TB is a very significant health concern for Myanmar,” the news service notes, adding, “Around 8,900 new cases of DR-TB are reported [in the country] each year, but only 800 patients had access to treatment at the end of 2012, he said.” IRIN writes, “From August 22 to 23, WHO, along with MSF and Myanmar’s Ministry of Health, plan to hold a DR-TB symposium in Yangon aimed at ramping up services throughout the country, including neglected border regions” (8/20).